TriSalus Life Sciences Stock

trisaluslifesci.comHealthcare / BioTech & PharmaFounded: 2009Funding to Date: $198.81MM

TriSalus Life Sciences is a biopharma company that specializes in treatment research and development for tumors of the liver and pancreas. TriSalus involves a team of clinicians and scientists who develop systemic immunotherapies to fight tumors through its developed drug delivery methods.

Register for Details

For more details on financing and valuation for TriSalus Life Sciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for TriSalus Life Sciences.

Register Today

Team

Management Team

Mary Szela
Chief Executive Officer and President
Steven C. Katz, MD, FACS
Chief Medical Officer, Scientific Advisory Board Chairman
Sean Murphy
Chief Financial Officer
Trevor McCaw
Chief Commercial Officer
Bryan F. Cox, PhD
Chief of Research
Jennifer L. Stevens, JD
Chief Regulatory Officer
Richard B. Marshak VMD, MBA
Business Development & Strategy, SVP

Board Members

Beverly Huss
Vibrynt
Sean Murphy
Malin Corporation
John Tullis
Tullis Health Partners
Norman Weldon
Partison Management Group
Karen Cassidy
Partisan Management Group
Mark T. Lupa
High Country Venture
Ginger Graham
Independent Director
Mats Wahlstrom
KMG Capital Partners

Other companies like TriSalus Life Sciences in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$4.74B